Frank A. Scappaticci
Frank A. Scappaticci publishes mostly in Oncology, Molecular Biology and Pulmonary and Respiratory Medicine, on topics such as Colorectal Cancer Treatments and Studies, Angiogenesis and VEGF in Cancer and Cancer Treatment and Pharmacology.
- World rank
- #830,686 of 7,710,434 ranked researchers
- Rank in United States
- #276,242 of 1,627,098
- Works
- 46
- Citations
- 3.7k
- Citations per work
- 81.2
What does Frank A. Scappaticci research?
Frank A. Scappaticci's work is mostly in Medicine (54%), Biochemistry, Genetics and Molecular Biology (30%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2553.6%
- Medicine2553.6%
- Life Sciences1429.6%
- Everything else816.8%
- 1Oncology30% of their works
- 2Molecular Biology22% of their works
- 3Pulmonary and Respiratory Medicine15% of their works
- 4Cancer Research8% of their works
- 5Surgery5% of their works
- 6Hepatology4% of their works
Research topics
Which keywords describe Frank A. Scappaticci's research?
The keywords of their largest research topics: Cetuximab, KRAS Mutations, Targeted Therapy, Chemotherapy-Induced Peripheral Neuropathy, endothelial progenitor cells, Taxanes, VEGF and ALK Inhibitors.
- Mutational Signatures
- Histone Deacetylases
- HIF-1
- Cancer Genomics
- ALK Inhibitors
- VEGF
- Chemotherapy-Induced Peripheral Neuropathy
- KRAS Mutations
- Cetuximab
- Targeted Therapy
- Taxanes
- endothelial progenitor cells
- EGFR Mutations
- HDAC Inhibitors
- Hepatocellular Carcinoma
- Liver Cancer
- Warburg Effect
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 17 words, with their numbers
- Cetuximab151 topic
- KRAS Mutations151 topic
- Targeted Therapy112 topics
- Chemotherapy-Induced Peripheral Neuropathy101 topic
- Taxanes101 topic
- VEGF101 topic
- endothelial progenitor cells101 topic
- ALK Inhibitors71 topic
- EGFR Mutations71 topic
- Cancer Genomics41 topic
- HDAC Inhibitors41 topic
- HIF-141 topic
- Hepatocellular Carcinoma41 topic
- Histone Deacetylases41 topic
- Liver Cancer41 topic
- Mutational Signatures41 topic
- Warburg Effect41 topic
Where does Frank A. Scappaticci work?
Frank A. Scappaticci's main affiliation in the publication record is Sarah Cannon, United States.
How many publications and citations does Frank A. Scappaticci have?
OpenAlex counts 46 works and 3,734 citations for Frank A. Scappaticci, an h-index of 23, ranking #830,686 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Frank A. Scappaticci. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.